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To characterise Ca
2þ-binding protein gene expression changes in oral squamous cell carcinomas (OSCCs), we compared the gene
expression profiles in OSCC-derived cell lines with normal oral tissues. One hundred Ca
2þ-binding protein genes differentially
expressed in OSCCs were identified, and genetic pathways associated with expression changes were generated. Among genes
mapped to the network with the highest significance, glucose-regulated protein 94kDa (Grp94) was evaluated further for mRNA and
protein expression in the OSCC cell lines, primary OSCCs, and oral premalignant lesions (OPLs). A significant (Po0.001)
overexpression of Grp94 protein was observed in all cell lines compared to normal oral epithelium. Immunohistochemical analysis
showed highly expressed Grp94 in primary OSCCs and OPLs, whereas most of the corresponding normal tissues had no protein
immunoreaction. Real-time quantitative reverse transcriptase-PCR data agreed with the protein expression status. Moreover,
overexpression of Grp94 in primary tumours was significantly (Po0.001) correlated with poor disease-free survival. The results
suggested that Grp94 may have potential clinical application as a novel diagnosis and prognostic biomarker for human OSCCs.
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Cytosolic Ca
2þ, a basic parameter of intracellular homeostasis, has a
wide variety of important cellular functions, that is, cell growth and
proliferation, processing and folding of endoplasmic reticulum
(ER)-translated proteins, and Ca
2þ-mediated signalling in response
to extracellular stimuli (Berridge et al, 2000; Kunzelmann, 2005).
Under physiologic conditions, many aspects of these processes are
mediated by members of the Ca
2þ-binding protein (Nelson and
Chazin, 1998). Since considerable evidence shows that intracellular
Ca
2þ deregulation is crucial for tumour growth and development
(Durham and Walton, 1982; Huang et al, 2005; Ding et al, 2006;
Thebault et al, 2006), understanding the genetic mechanisms of the
Ca
2þ-binding protein genes involved in carcinogenesis is impera-
tive for the development of new therapeutic strategies.
Ca
2þ-binding protein is characterised by the presence of the
putative Ca
2þ-binding domain; EF-hand structure is an essential
mediator of intracellular Ca
2þ control elements, such as the
plasma membrane Ca
2þ pumps or ER (Koch et al, 1986; Nelson
and Chazin, 1998; Haeseleer et al, 2000). A number of Ca
2þ-
binding proteins are thought to be implicated in establishing the
malignant and metastatic phenotypes of various tumours (Chen
et al, 1997; Takenaga et al, 1997; Van Ginkel et al, 1998), and
recent studies have reported altered expression of several Ca
2þ-
binding protein genes in a wide range of human malignancies
(Bustin et al, 2001; Pietas et al, 2002; Lakshmikuttyamma et al,
2004; Imazawa et al, 2005). Regarding oral squamous cell
carcinomas (OSCCs), aberrant expression of S100 Ca
2þ-binding
protein families seen in tumour sites has been correlated with
cancer cell invasion or metastasis (Moriyama-Kita et al, 2004; Tsai
et al, 2005). We recently identified certain Ca
2þ-binding protein
genes differentially expressed in OSCCs compared with normal
oral squamous epithelium, including PMCA1 (Saito et al, 2006),
ITPKA (Kato et al, 2006), ATP2A2 (Endo et al, 2004), CALR
(Shimada et al, 2005), and E-cadherin (Saito et al, 1998).
We recently developed the strategy of using a knowledge-based
network approach to search for candidate genes relevant to the
treatment of oral cancers (Kasamatsu et al, 2005; Higo et al, 2006;
Ishigami et al, 2007). Thus, this study aimed to explore further the
global changes in Ca
2þ-binding protein genes associated with
OSCCs by applying network development tools to expand on
microarray analysis methods. In addition, a candidate gene for
therapeutic targeting and follow-up studies was evaluated further
for the expression status of the mRNA and protein in a large series
of OSCCs and oral premalignant lesions (OPLs).
MATERIALS AND METHODS
Tissue specimens
Eighty pairs of primary OSCC samples and corresponding normal
oral epithelial tissues or 20 OPLs (diagnosed as oral leukoplakias)
were obtained at the time of surgery performed at Chiba University
Hospital between 1998 and 2005. All patients provided informed
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sconsent according to the protocol that was reviewed and approved
by the Institutional Review Board of Chiba University before any
procedures were performed. Postoperative follow-up data were
collected until April 2006 or until the day of the patient’s death,
metastasis, or local recurrence. The median follow-up time was 2.1
years (range: 3 months to 8 years).
The resected tissues were divided into two parts: one was frozen
immediately after removal of the surrounding normal tissue and
stored at  801C until RNA extraction, and another was fixed in
10% buffered formaldehyde solution for pathologic diagnosis and
immunohistochemical staining. Histopathologic diagnosis of each
tumour specimen was performed according to the International
Histological Classification of Tumours by the Department of
Pathology, Chiba University Hospital. Clinicopathologic staging
was determined by the TNM classification of the International
Union against Cancer. All OSCC samples were histologically
confirmed and checked to ensure the presence of tumour in
greater than 80% of specimens.
Formalin-fixed, paraffin-embedded human breast cancer tissue
(positive control for Grp94 expression) was purchased from Lab
Vision Co., Fremont, CA, USA (GRP94, Ab-1, positive control for
immunohistochemistry).
Cell culture
The OSCC-derived cell lines used in this study were HSC-2, HSC-3,
Ca9-22 (Human Science Research Resources Bank, Osaka, Japan),
H-1, Sa-3 (provided by Dr Fujita, Wakayama Medical University,
Wakayama, Japan), and OK-92 (established from carcinoma of the
tongue in our department) (Takahashi et al, 1989). All OSCC-
derived cell lines were cultured in Dulbecco’s modified Eagle’s
medium F-12 HAM (Sigma-Aldrich Co., St Louis, MO, USA)
supplied with 10% heat-inactivated fetal bovine serum (Sigma) and
50Uml
 1 penicillin and streptomycin (Sigma). The human normal
oral keratinocytes (HNOKs) cell line was cultured and maintained
in defined keratinocyte-SFM (Gibco BRL, Gaithusberg, Germany).
All cell lines were incubated at 371C in a humidified atmosphere
with 5% CO2.
Protein and mRNA extraction
Protein was extracted when the cells reached 80–90% confluence;
they were washed two times with phosphate-buffered saline (PBS),
scraped into a tube, and centrifuged briefly. The cell pellets were
incubated for 30min in a lysis buffer (LB) containing 7 M urea, 2 M
thiourea, 4% wv
 1 CHAPS, and 10mM Tris pH 8.0, and lysed by
sonication (3 10s pulses on ice). The sample was centrifuged at
13000r.p.m. for 20min. The supernatant containing the cell
proteins then was recovered and the protein concentration was
measured with a Protein Assay Kit (Bio-Rad Laboratories,
Hercules, CA, USA) and adjusted to 1mgml
 1 with LB. The pH
of the protein sample was adjusted to 8.5 with 30mM Tris–HCl.
Total RNA was extracted using Trizol reagent (Invitrogen Life
Technologies, Carlsbad, CA, USA) according to the manufacturer’s
instructions. Total protein extracted from a human breast cancer
cell line, SKBR3 (positive control for Grp94 expression), was
obtained from Lab Vision (GRP94, Ab-1, positive control for
Western blotting). Each extracted RNA or protein was stored
separately at  801C until use.
Affymetrix GeneChip hybridisation
Double-stranded cDNA was synthesised from 20mg of total RNA
using the Superscript Choice system (Invitrogen). After phenol/
chloroform extraction and ethanol precipitation, a biotin-labelled
in vitro transcription reaction was carried out using the cDNA
template (Enzo Bioarray, Farmingdale, NY, USA). cRNA (7mg) was
fragmented according to Affymetrix protocols and added to the
recommended hybridisation mixture. Expression profiles were
created using the Human Genome U 133 Plus 2.0 arrays containing
54675 probe sets (Affymetrix, Santa Clara, CA, USA). Arrays were
stained with phycoerythrin–streptavidin, and the signal intensity
was amplified by treatment with a biotin-conjugated anti-
streptavidin antibody followed by a second staining with
phycoerythrin–streptavidin. Arrays stained a second time were
scanned using the Affymetrix GeneChip Scanner 3000 (Affyme-
trix). Expression data were analysed using GeneChip Operating
Software 1.1 (Affymetrix), and Ca
2þ-binding protein genes were
then classified by GeneSpring 6.1 (Silicon Genetics, Redwood City,
CA, USA).
Network and gene ontology analysis
A list of Ca
2þ-binding protein genes identified by microarray
analysis was used for network and gene ontology analyses. Gene
accession numbers were imported into the Ingenuity Pathway
Analysis (IPA) Software (Ingenuity Systems, Mountain View, CA,
USA). The IPA database consists of proprietary ontology
representing 300000 biologic objects ranging from genes, proteins,
and molecular and cellular processes. More than 11200 human
genes are currently represented in the database. The genes were
categorised based on location, cellular components, and reported
or suggested biochemical, biologic, and molecular functions using
the software. The identified genes also were mapped to genetic
networks available in the Ingenuity database and then ranked by
score. The score is the probability that a collection of genes equal
to or greater than the number in a network could be achieved by
chance alone. A score of 3 indicates a 1/1000 chance that the focus
genes are in a network due to random chance. Therefore, a score of
3 or higher has a 99.9% confidence level of not being generated by
random chance alone. This score was used as the cutoff for
identifying gene networks.
Western blot analysis
Among genes identified, glucose-regulated protein 94kDa (Grp94)
was selected for further analyses. We carried out Western blot
analysis to investigate Grp94 protein expression in normal oral
epithelium and OSCC-derived cell lines. Protein extracts were
electrophoresed on 11% sodium dodecyl sulphate-polyacrylamide
gel electrophoresis gels, transferred to polyvinylidene difluoride
(PVDF) membranes (Bio-Rad Laboratories, Hercules, CA, USA),
and blocked for 1h at room temperature in 5% skim milk.
Immunoblot PVDF membranes were washed with 0.1% Tween-20
in TBS (TBS-T) five times, and 2mgml
 1 affinity-purified rat
antihuman Grp94 monoclonal antibody (Lab Vision) was added
directly to the TBS-T solution for 2h at room temperature. The
PVDF membranes were washed again and incubated with 1:10000
ratio of horseradish peroxidase (HRP)-conjugated antirat IgG Ab
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) as a secondary
antibody for 20min at room temperature. The membranes were
then incubated with enhanced chemiluminescence (ECL) þHRP
substrate solution included in the ECLþ kit (Amersham
Biosciences, Buckinghamshire, UK), and immunoblotting was
visualised by exposing the membrane to Hyperfilm (Amersham
Biosciences). Triplicate examinations were performed to confirm
the specificity of the antibody.
Immunofluorescence
The cells grown on glass coverslips were washed with PBS, fixed in
4% paraformaldehyde for 10min at 371C followed by absolute
methanol for 10min at 41C, and blocked in PBS containing 1%
skimmed milk for 10min. The samples then were incubated with
anti-Grp94 antibody (Lab Vision) at a dilution of 1:100 for 2h,
rinsed two times with PBS, and incubated with goat antirat
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ssecondary antibody labelled with Alexa Fluor 546 (Molecular
Probes, Leiden, The Netherlands) for 1h. For counterstaining of
the nucleus, the dishes were then incubated with 1mgml
 1
Cellstain-DAPI (Dojindo Laboratories, Kumamoto, Japan) in PBS
for 10min. The samples were observed under a Leica TCS2-MP
confocal system (Leica Laserteknik, Mannheim, Germany) and
Coherent Mira tunable pulsed titanium sapphire laser (Coherent
Laser Group, Santa Clara, CA, USA).
Immunohistochemistry
To examine the cellular distribution of Grp94 protein in normal
and OSCCs, we carried out immunohistochemical staining on
4-mm sections of paraffin-embedded specimens. Briefly, after
deparaffinisation and hydration, the slides were pretreated in
10mM sodium citrate buffer (pH 6.0) in a microwave oven for
5min at 951C. The endogenous peroxidase activity was quenched
G-protein
coupled receptor
Nodes
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NOS2A
TGM1
PLA2G2A
PLCD1
PLA2G10 RYR1
Figure 1 Network with the highest score (network 1). Expression levels of all 35 genes (100%) are altered significantly in the oral squamous cell
carcinomas (OSCCs). Functional relationships between gene products based on known interactions in ingenuity pathway analysis (IPA) knowledge are
described.
Table 1 Genetic networks in the OSCC-derived cell lines
Network Genes in ingenuity networks
a Function Score
b
1 ATGR1, BDKRB2, CACNA1B, CACNA1C, CACNA1S, CACNB1, CACNG1,
CAPN3, CAPN9, CCL2, CCL3, CCL5, CCL7, CCL13, CCL14, CCL15, CCR1,
CCR5, CSPG2, CXCL12, DSG2, EGF, EPS15, F10, MYL2, NOS2A, PLA2G10,
PLA2G2A, PLCD1, PLEK, PRKCA, RASGRP3, RYR1, TGM1, Grp94
Cell signalling, cellular function,
and maintenance
71
2 AGT1, ANXA1, ATF1, CALML3, CDH11, COPS5, DIABLO, DGS3, FGF10, FPR1, IL11,
IR1RN, INHBA, LTBP2, MGP, MMP8, MMP13, MTPN, NOTCH4, PCDH7, RXRA,
S100A7, S100A8, S100A9, SAA1, SCARB1, SCUBE1, SCUBE9, SERPINA3, SOD1, TNF,
TNFRSF4, TNFRSF9, TPO, UMOD
Lipid metabolism, molecular
transport
20
3 AKT1, ATP2A3, BAG3, BBC3, BCL2, CALU, CCL19, CCR7, CDH5, CHGB, CHP,
CIB1, CKS2, CLCN3, E2F4, EGF, ETS1, ITPR3, JUB, KRAS, LOCG3928, MIG-6, MYL1,
PPP2R3A, PRKCSH, RALGDS, RASGRP1, RBL1, ROCK1, RPS6KB2, RRM1, RRM2,
SLC3A2, SLC9A1, TERT
Cancer, cell morphology,
cellular compromise
20
4 AHNAK, ATP2A1, BBC3, BGN, BMP1, CANX, CCR6, CDKN1B, CHGA, CHRD,
COL5A1, CTSD, CUBN, DDX5, DMP1, FBLN5, FREQ, GFAP, GHR, IER3, IGF1, INPPL1,
LGALS3, LOX, LPL, METAP2, MRC1, MTPN, MYC, PLS1, S100A1, S100B, SLC2A4,
TLL1
DNA replication,
recombination, and
developmental disorder,
carbohydrate
17
5 C2, C3, C1QA, C1S, C3AR1, CCL2, DSC1, DSG1, F13A1, HOXD3, IGFBP2, IGFBP5,
IL13, ITIH1, JUP, KLK5, MMP2, MMP13, MMP14, MYOD1, PROC, RP6SKA2, S100A4,
SERPINA1, SLIT2, SPOK3, TGM2, THBS1, THBS2, TIMP1, TKT, TNNC1, TNNC2,
TNNI1, TNNT2
Organism, injury and
abnormalities, cardiovascular
system
17
6 ACTN2, ACTN3, CALM1, CASQ1, CD47, CDK6, CDKN1A, CTSK, CXCL12, DCN,
ERBB2, ERBB3, ERBB4, EREG, FBLN2, FBN1, GHR, GRB7, GRK1, HAS2, HBEGF, HRC,
IFNA2, IL6R, MTPN, MYL9, MYOZ1, PTGS1, RCV1, S100A4, SERPINA3, TGM1, TIMP3,
TNC, TRDN
Cellular growth and
proliferation, cellular
movement, cell death
17
aGenes in boldface were identified by microarray analysis to be expressed differentially more than two-fold in OSCCs. Other genes were either not on the expression array or
not significantly regulated.
bA score43 was considered significant.
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sby 30-min incubation in a mixture of 0.3% hydrogen peroxide
solution in 100% methanol. After being washed with PBS buffer,
sections then were incubated with primary antibody antiGrp94
antibody (1:100 dilution) at room temperature in a moist chamber
for 2h. After being washed with PBS buffer, the slides were treated
with biotinylated secondary antibody for 1h followed by colour
development in 3,30-diaminobenzidine tetrahydrochloride (Dako
Japan Inc., Kyoto, Japan). Finally, the slides were lightly counter-
stained with haematoxylin. A known positive breast cancer control
section for Grp94 was clearly stained. While the breast cancer cells
were immunohistochemically positive for Grp94, those of the
negative control prepared by omitting the primary antibody were
negative, thus confirming the staining specificity. To quantitate the
state of the Grp94 protein expression, the mean percentage of
positive tumour cells was determined in at least five random fields
at  400 magnification in each section. The intensity of the Grp94
immunoreaction was scored as follows: 1þ, weak; 2þ, moderate;
and 3þ, intense. The percentage of positive tumour cells and the
staining intensity were then multiplied to produce a Grp94-
immunohistochemical staining score. Cases with a Grp94-immuno-
histochemical staining score exceeding 65.56 (maximum score
of normal tissues) were considered positive. Two independent
pathologists, neither of whom had knowledge of the patients’
clinical status, made these judgments.
mRNA expression analysis
The expression levels of Grp94 mRNA were examined in 50 OSCC
specimens from patients with primary tumours among the OSCC
cases studied by immunohistochemical staining. Control reactions
were prepared in parallel without reverse transcriptase (RT).
Before cDNA synthesis, residual genomic DNA was removed from
the total RNA using DNase I treatment (DNA-free; Ambion,
Austin, TX, USA). The primer sequences used to analyse Grp94
mRNA expression were 50-AGCAAGACGTGTTCGATTC-30 (nu-
cleotides 1392–1410) and 50-CCTCAATTTTGTCAAGGGTG-30
(nucleotides 1607–1626). The sequences of specific primers were
checked before use to avoid amplification of genomic DNA or
pseudogenes by the Primer3 program (available at http:www-
genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi). Amplified
products were analysed by 3% agarose gel electrophoresis to
ascertain size and purity. Real-time quantitative RT (qRT)–PCR
Table 2 Thirty-five focus genes in network 1
Affymetrix no. Gene Molecular function Location Fold change
a
217901_at DSG2 Cell adhesion Plasma membrane 85.187
200599_s_at Grp94 Protein folding and sorting, antigen presentation Plasma membrane 5.479
210037_s_at NOS2A Nitric oxide synthase activity Cytoplasm 5.072
1560074_at PRKCA Protein kinase C activity Cytoplasm 3.781
210641_at CAPN9 Calpain activity Unknown 3.003
207162_s_at CACNA1B Voltage-gated calcium channel activity Plasma membrane 2.894
207222_at PLA2G10 Unknown Extracellular space 2.749
207225_at EPS15 Protein binding Plasma membrane 0.4539
201511_at BDKRB2 Receptor activity Plasma membrane 0.4464
205434_s_at CACNA1C Voltage-gated calcium channel activity Plasma membrane 0.4288
218075_at AGTR1 Receptor activity Plasma membrane 0.3305
1558450_at CCR1 Chemokine receptor activity Plasma membrane 0.2580
207798_s_at CACNB1 Voltage-gated calcium channel activity Plasma membrane 0.2346
228767_at CCL13 Chemokine receptor activity Extracellular space 0.2200
235070_at PLEK Reorganisation Cytoplasm 0.1697
229819_at CCR5 Chemokine receptor activity Plasma membrane 0.1640
228376_at CCL7 Chemokine receptor activity Extracellular space 0.1611
218529_at F10 Peptidase activity Extracellular space 0.1583
224938_at PLA2G2A Protein binding Extracellular space 0.1339
224939_at CACNA1S Voltage-gated calcium channel activity Plasma membrane 0.1256
214711_at CCL5 Chemokine receptor activity Extracellular space 0.1172
214319_at CCL3 Chemokine receptor activity Extracellular space 0.1071
1555904_at CCL15 Chemokine receptor activity Extracellular space 0.0868
209665_at RASGRP3 Protein binding Cytoplasm 0.0810
220781_at CACNG1 Voltage-gated calcium channel activity Plasma membrane 0.0744
1553086_at CSPG2 Unknown Extracellular space 0.0736
212698_s_at EGF Protein binding Extracellular space 0.0611
226627_at PLCD1 Unknown Cytoplasm 0.0381
213666_at CXCL12 Chemokine receptor activity Extracellular space 0.0350
211890_x_at CAPN3 Calpain activity Cytoplasm 0.0227
216598_s_at CCL2 Chemokine receptor activity Extracellular space 0.0198
235340_at CCL14 Chemokine receptor activity Extracellular space 0.0165
205485_at RYR1 Voltage-gated calcium channel activity Plasma membrane 0.0126
206008_at TGM1 Cell formation Plasma membrane 0.0109
209742_s_at MYL2 Motor activity Cytoplasm 0.0100
AGTR1¼angiotensin II receptor, type 1; BDKRB2¼bradykinin receptor B2; CACNA1B¼calcium channel, voltage-dependent, L type, a 1B- subunit; CACNA1C¼calcium
channel, voltage-dependent, L type, a 1C subunit; CACNA1S¼calcium channel, voltage-dependent, L type, a 1S subunit; CACNB1¼calcium channel, voltage-dependent, b 1
subunit; CACNG1¼calcium channel, voltage-dependent, g subunit 1; CAPN3¼calpain 3, (p94); CAPN9¼calpain 9; CCL2¼chemokine (C-C motif) ligand 2;
CCL3¼chemokine (C-C motif) ligand 3; CCL5¼chemokine (C-C motif) ligand 5; CCL7¼chemokine (C-C motif) ligand 7; CCL13¼chemokine (C-C motif) ligand 13;
CCL14¼chemokine (C-C motif) ligand 14; CCL15¼chemokine (C-C motif) ligand 15; CCR1chemokine (C-C motif); CCR5¼chemokine (C-C motif) receptor 5;
CSPG2¼chondroitin sulfate proteoglycan 2; CXCL12¼chemokine (C-X-C motif) ligand 12; DSG2¼desmoglein 2; EGF¼epidermal growth factor; EPS15¼epidermal growth
factor receptor pathway substrate 15; F10¼coagulation factor X; Grp94¼glucose regulated protein, 94 kDa; MYL2¼myosin, light polypeptide 2, regulatory, cardiac, slow;
NOS2A¼nitric oxide synthase 2A; PLA2G2A¼phospholipase A2, group IIA; PLA2G10¼phospholipase A2, group X; PLCD1¼phospholipase C, delta 1; PLEK¼pleckstrin;
PRKCA¼protein kinase C, a; RASGRP3¼RAS guanyl releasing protein 3; RYR1¼ryanodine receptor 1; TGM1¼transglutaminase 1.
aFold overexpression for microarray data
of OSCC-derived cell lines compared to normal control.
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swas performed with a single method using the LightCycler
FastStart DNA Master SYBR Green I kit (Roche, Mannheim,
Germany). To prepare the standard curve, 3mg of total RNA from
normal oral tissue was reverse-transcribed with Superscript RT
(Life Technologies, Grand Island, NY, USA) and oligo-d(T)12-18
primer, after which serial dilutions were made corresponding to
cDNA transcribed from 300, 30, 3.0, and 0.3ng of total RNA. PCRs
using LightCycler apparatus were carried out in a final volume of
20ml of reaction mixture consisting of 2ml of FirstStart DNA
Master SYBR Green I mix, 3mM MgCl2, and 0.2ml of primers,
according to the manufacturer’s instructions. The reaction mixture
then was loaded into glass capillary tubes and submitted to an
initial denaturation at 951C for 10min, followed by 45 rounds of
amplification at 951C 10s) for denaturation, 581C (10s) for
annealing and 721C for extension, with a temperature slope of
201Cs
 1, performed in the LightCycler. The transcript amount for
Grp94 was estimated from the respective standard curves and
normalised to the GAPDH transcript amount determined in
corresponding samples.
Statistical analysis
Differences in gene expression levels between Grp94-positive and
Grp94-negative cases were calculated with the Mann–Whitney’s
U-test. Correlations between Grp94-immunohistochemical stain-
ing scores and clinicopathologic features were evaluated by
Fisher’s exact test. Overall survival time was defined as the interval
between the date of treatment and the date of death or until the last
objective follow-up information was obtained. Disease-free survi-
val time was regarded as the time interval between tumour
treatment and detection of the first locoregional recurrence,
distant metastasis, or both or the date of the last follow-up,
whichever occurred first. Patients without evidence of disease
(local recurrence or metastasis) during follow-up were considered
to have a good prognosis; patients with local recurrence, distant
metastasis during follow-up were regarded as having a poor
prognosis. Survival curves were obtained by the Kaplan–Meier
method and differences in survival rates between Grp94-positive
and Grp94-negative cases were compared by log-rank tests with
95% significance. The criterion for statistical significance was
Po0.05. The data are expressed as the mean values±s.e.
RESULTS
Altered Ca
2þ-binding protein genes expression in
OSCC-derived cell lines
To investigate the expression profile changes of Ca
2þ-binding
protein genes in OSCC, we initially performed oligonucleotide
microarray analyses using the Affymetrix U133A chips, which
contained 54675 probe sets with RNAs isolated from four OSCC-
derived cell lines (HSC-2, HSC-3, H-1, and Sa-3). Control RNAs
consisted of a pool made of normal tongue tissue RNAs extracted
from three patients. Expression data were analysed using the
GeneChip Operating Software 1.1 (Affymetrix) and GeneSpring 6.1
(Silicon Genetics). Of the 2241 Ca
2þ-binding protein gene
transcripts analysed, 100 (4.4%) were identified as genes that were
differentially expressed at least two-fold in all OSCC-derived cell
lines examined compared with controls. Of these, 24 genes were
found to be upregulated and 76 genes were downregulated in
OSCC (data not shown).
Network and gene ontology analysis
On the basis of all genes identified as described previously
(referred to as focus genes), new and expanded pathway maps and
connections and specific gene–gene interactions were inferred,
functionally analysed, and used to build on the existing pathway
using the IPA knowledge base. To generate networks, the
knowledge base was queried for interactions between focus genes
and all other gene objects stored in the database. Six networks were
found to be significant in OSCC in that they had more of the
identified genes present than would be expected by chance
(Table 1). Of them, the network with the highest score (network
1, score¼71) was generated with all focus genes (Figure 1;
Table 2). We also performed gene ontology analyses of 100 focus
genes using the IPA tool. Seventy-six upregulated genes were
associated with cancer-related functions, cell death, and the cell
cycle; 24 downregulated genes were associated with cellular
movement, signalling, and function and maintenance (Table 3).
In particular, we found that the cellular signalling was contained in
both the upregulated and downregulated groups. Six upregulated
genes were associated with a variety of cellular signalling
functions, including induction/production of nitric oxide, inhibi-
tion of cyclic adenosine monophosphate, and inactivation of
mitogen-activated protein kinase. In contrast, 31 downregulated
groups played a critical role in cellular signalling, which is related
Table 3 Functional characterisation of Ca
2+-binding protein genes
altered expressed in OSCC-derived cell lines
Relevant function and disease P-value
Gene,
no
a
Top-10 functions associated with upregulated genes in OSCC-derived cell lines
Cancer
b 1.15E 3t o
4.27E 2
7
Cell death 1.15E 3t o
6.42E 2
4
Cell cycle 1.86E 3t o
6.95E 2
6
Cell-to-cell signalling and interaction 3.94E 3t o
6.16E 2
7
Cell signalling 3.29E 3t o
6.42E 2
6
Molecular transport 4.29E 3t o
7.47E 2
5
Small molecule biochemistry 4.29E 3t o
7.47E 2
9
Nucleic acid metabolism 5.07E 3t o
2.89E 2
4
Cellular growth and proliferation 5.07E 3t o
6.95E 2
3
Cell morphology 8.24E 3t o
6.95E 2
1
Top-10 functions associated with downregulated genes in OSCC-derived cell lines
Cellular movement
c 1.60E 13 to
8.53E 3
33
Cellular signalling 1.52E 11 to
8.53E 3
31
Cellular function and maintenance 1.52E 11 to
8.53E 3
16
Small molecule biochemistry 1.52E 11 to
8.53E 3
20
Vitamin and mineral metabolism 1.52E 11 to
7.02E 3
32
Tissue morphology 2.10E 11 to
8.53E 3
33
Molecular transport 2.69E 11 to
8.53E 3
18
Skeletal and vascular system development and
function
2.08E 10 to
8.53E 3
21
Cancer 5.13E 9t o
8.53E 3
27
Cell-to-cell signalling and interaction 1.01E 8t o
8.53E 3
26
aNumber of associated genes.
bApoptosis, cell movement, proliferation, cell cycle
progression, migration, binding quantity of cancer cell line.
cChemotaxis, migration,
cell movement, mobilisation of haematologic cyte.
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sto intracellular Ca
2þ homeostasis, suggesting that genes associated
with cell signalling may act in a different manner during
development of OSCC.
Among genes mapped to the network with the highest
significance, Grp94 was analysed further.
GRP94 expression in OSCCs
The state of Grp94 protein expression in six OSCC-derived cell
lines (HSC-2, HSC-3, H-1, Sa-3, Ca9-22, and OK-92) (n¼6) was
evaluated by Western blot analysis. Figure 2A shows representative
results. The band size was found to be 94kDa as a single band, as
reported by Little et al (1994). A significant (Po0.001) over-
expression of Grp94 protein was observed in all OSCC-derived cell
lines compared with normal oral epithelium. We also assessed the
level of Grp94 protein expression in an OSCC-derived cell line
(HSC-3) and HNOKs by immunofluorescence analysis. Represen-
tative cases of immunofluorescence are shown in Figure 2B. Strong
immunoreactivity of Grp94 protein was detected in the cytoplasm
of the OSCC-derived cell line HSC-3 compared with the HNOKs.
Immunohistochemical staining was performed using a series of
surgical OSCC specimens, including 80 OSCCs with corresponding
normal tissues and 20 OPLs. Grp94 overexpression was found not
only in OSCCs (Po0.001) but also in OPLs (Po0.001). Among the
OSCCs, 46 had significantly increased expression of Grp94
(immunohistochemical staining score, 465.56). In contrast, the
normal tissues had no or significant downregulation of Grp94
expression and were considered Grp94 negative (Fisher’s exact
test). There was no significant difference between the frequency of
Grp94-positive cases and clinicopathologic features (Table 4).
Thirteen of 20 (65%) OPLs were defined as Grp94 positive. The
Grp94-immunohistochemical staining scores for normal tissues,
OPLs, and OSCCs, respectively, ranged from 0 to 65 (mean,
12.173), 12 to 191 (mean, 85.27), and 0 to 262 (mean, 106.511)
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Figure 2 Representative results of expression of Grp94 protein in oral squamous cell carcinomas (OSCC)-derived cell lines. (A) Western blot analysis of
Grp94 protein in OSCC-derived cell lines and normal oral epithelium. All OSCC-derived cell line extracts exhibit a single band for Grp94 protein expression
at high levels. In contrast, normal oral epithelium shows a low level of Grp94 protein expression. (B) Immunocytochemical analysis shows strong
immunoreactivity of Grp94 in an OSCC-derived cell line (HSC-3) compared with human normal oral keratinocytes (HNOKs). DAPI staining was used to
stain DNA. Bar, 100mm. (C) Immunohistochemical staining of Grp94 in normal tissue, oral premalignant lesion (OPL), and primary OSCC. (a) Normal oral
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s(Figure 2C). Grp94 expression levels in primary OSCCs and
OPLs were significantly (Po0.001) higher than those in normal
oral tissues (Figure 3). In contrast, we found no significant
(P¼0.448334) difference in Grp94-immunohistochemical staining
scores between OSCCs and OPLs.
Grp94 mRNA expression levels were significantly upregulated in
primary tumours of randomly selected Grp94-positive cases
(n¼29) compared to selected Grp94-negative cases (n¼21,
Mann–Whitney U-test, Po0.001; Figure 4A). mRNA expression
levels were normalised to GAPDH. The relative mRNA expression
levels in positive and negative cases ranged from 113 to 297 (mean,
191.3) and 9 to 88 (mean, 56.6), respectively. Grp94 expression was
upregulated significantly in all OSCC cell lines examined compared
to normal oral epithelium used as a control (Figure 4B).
Prognostic significance of GRP94 expression in OSCCs
To assess whether Grp94 expression also had a prognostic impact
on patients with OSCC, clinical postoperative data from patients
Table 4 Correlation between Grp94 expression and clinical classification
in OSCCs
Result of immunostaining:
number of patients(%)
Clinical classification Total Grp94 ( ) Grp94 (+) P-value
a
Age at surgery (years)
o60 23 8 (30) 15 (70)
60p, o70 26 11 (42) 15 (58) 0.431974
70p 31 15 (48) 16 (52)
Gender
Male 33 13 (39) 20 (61) 0.654387
Female 47 21 (45) 26 (55)
T-primary tumour
T1 5 2 (40) 3 (60)
T2 35 15 (43) 20 (57) 0.55542
T3 17 5 (29) 12 (71)
T4 23 12 (52) 11 (48)
N-regional lymph node
N( ) 52 23 (44) 29 (56) 0.813185
N(+) 28 11 (39) 17 (61)
Stage
I 5 2 (40) 3 (60)
II 16 7 (44) 9 (56) 0.756529
III 17 7 (41) 10 (59)
IV 52 28 (54) 24 (46)
Histopathologic type
Well differentiated 51 24 (47) 27 (53)
Moderately differentiated 22 9 (41) 13 (59) 0.300615
Poorly differentiated 7 1 (14) 6 (86)
Tumour site
Tongue 34 12 (35) 22 (65)
Gingiva 29 13 (45) 16 (55) 0.90283
Oral floor 7 3 (43) 4 (57)
Buccal mucosa 6 3 (50) 3 (50)
Oropharynx 3 2 (67) 1 (33)
Lip 1 0 (0) 1 (100)
Leukoplakia 20 7 (35) 13 (65) —
aPo0.05 was considered significant.
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swhose tissue samples were investigated for Grp94 protein
expression by immunohistochemical analysis were statistically
analysed. Tumours with significantly increased expression levels of
Grp94 protein (immunohistochemical staining score, 465.56;
maximum score of normal tissues) were defined as Grp94 positive
(n¼46). Cases with no or significant downregulation of Grp94
protein expression (immunohistochemical staining score, o65.56)
were considered Grp94 negative (n¼34).
Survival curves in relation to Grp94 protein expression are
shown in Figure 5. Log-rank survival analysis indicated that
Grp94-positive expression was significant both for disease-free
survival (P¼0.011; Figure 5A) and overall survival (P¼0.024;
Figure 5B), which suggested that high expression of Grp94 protein
in patients with OSCCs was significantly associated with a poor
prognosis.
DISCUSSION
Using a microarray technique, we identified a total of 100 Ca
2þ-
binding protein genes aberrantly expressed in OSCC cells. Pathway
analysis could further characterise six networks from the 100 genes
(Table 1). In addition, the network of the highest significance was
generated entirely from 35 of the 100 focus genes (Figure 1),
including a number of the CCL and CXC families. Previous studies
have shown that chemokine-mediated JAK/STAT activation is
critical for phospholipase C-b dependent Ca
2þ flux (Li et al, 2000;
Lewis, 2001; Thelen, 2001; Soriano et al, 2003). This evidence
together with the current results suggests that reduced expression
of the main chemokine families, CCL and CXC, disrupts
intracellular Ca
2þ homeostasis and initiates oral tumorigenesis.
The network with the highest significance also contained several
cancer-related genes with high expression levels, including DSG2,
PRKCA, PLA2G10, and Grp94.
Considerable evidence has shown a significant association
between the heat-shock protein 90 (Hsp90) and a wide range of
human malignancies, including head and neck cancers (Ito et al,
1998; Baker et al, 2005; Yin et al, 2005). Grp94, also known as gp96,
is the ER-resident member of the Hsp90 family constitutively
expressed in virtually all cell types (Van et al, 1989) and the most
abundant ER chaperon protein showing high homology (50%) to
cytosolic counterpart Hsp90 (Sorger and Pelham, 1987). Increased
expression of Grp94 both at the mRNA and protein levels also has
been reported in several types of human cancers, such as
oesophageal cancer (Wang et al, 2005b), lung cancer (Wang
et al, 2005a), breast cancer (Gazit et al, 1999), liver cancer (Lim
et al, 2005), and colon cancer (Wang et al, 2005c). We
hypothesised that Grp94 also has potential as an emerging
therapeutic target of interest for the treatment of oral cancer.
However, the status of Grp94 in OSCC remains unclear and,
therefore, we selected it for further investigation.
To confirm our hypothesis, we determined the protein/mRNA
expression in a series of OSCC-derived cell lines and human
primary OSCCs using immunofluorescence, Western blot analysis,
qRT–PCR, and immunohistochemistry. Significant increases in
Grp94-protein- and mRNA-expression levels were observed in the
OSCC-derived cell lines examined compared with the normal oral
epithelium. We also detected a comparatively strong tumour cell-
localised cytoplasmic Grp94-immunoreaction in primary OSCCs.
By evaluating the Grp94 immunohistochemistry scores, significant
upregulation was evident in the primary OSCCs compared with
normal tissues. While we could not find a significant correlation
between Grp94 protein expression status and any clinicopathologic
features examined, high levels of Grp94 protein expression was
detected even in the OPLs examined. In addition, the current study
showed that Grp94 overexpression is closely related to the disease-
free/overall survival (P¼0.011 and 0.024, respectively). Thus, we
suggest that Grp94 could be associated with not only early-stage
OSCC development but also tumour prognosis.
Interestingly, a recent study has shown that inhibition of Grp94
expression by geldanamycin in chronic lymphocytic leukaemia
cells induces apoptosis with modest cytoprotective effects of
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sprimary haematopoietic progenitors from normal bone marrow
(Jones et al, 2004). In addition, targeting cancer cells with an
antisense or RNAi procedure against Grp94 has shown increased
chemosensitivity or radiosensitivity (Reddy et al, 1999; Kubota
et al, 2005). From the therapeutic standpoint, this evidence may
provide a novel/effective approach for treating human OSCCs.
In summary, we found novel specific networks of Ca
2þ-binding
protein genes in OSCC cells and identified several candidate genes
for molecular targeting, especially for Grp94. Our findings may
contribute to an understanding of key biologic functions and
pathways of certain Ca
2þ-binding protein genes associated with
OSCC and should stimulate further investigation into Ca
2þ-
binding protein genes relevant to oral carcinogenesis.
ACKNOWLEDGEMENTS
We thank Lynda C Charters for editing this article. This study was
partly supported by a Grant-in-Aid Scientific Research (no.
16591820) from the Ministry of Education, Culture, Sports,
Science, and Technology of Japan.
REFERENCES
Baker H, Patel V, Molinolo AA, Shillitoe EJ, Ensley JF, Yoo GH, Meneses-
Garcia A, Myers JN, El-Naggar AK, Gutkind JS, Hancock WS (2005)
Proteome-wide analysis of head and neck squamous cell carcinomas
using laser-capture microdissection and tandem mass spectrometry. Oral
Oncol 2: 183–199
Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of
calcium signalling. Nat Rev Mol Cell Biol 1: 11–21
Bustin SA, Li SR, Dorudi S (2001) Expression of the Ca2+-activated
chloride channel genes CLCA1 and CLCA2 is downregulated in human
colorectal cancer. DNA Cell Biol 20: 331–338
Chen D, Davies MP, Rudland PS, Barraclough R (1997) Transcriptional
down-regulation of the metastasis-inducing S100A4 (p9Ka) in benign but
not in malignant rat mammary epithelial cells by GC-factor. J Biol Chem
272: 20283–20290
Ding Y, Robbins J, Fraser SP, Grimes JA, Djamgoz MB (2006) Comparative
studies of intracellular Ca
2+ in strongly and weakly metastatic rat
prostate cancer cell lines. Int J Biochem Cell Biol 38: 366–375
Durham AC, Walton JM (1982) Calcium ions and the control of
proliferation in normal and cancer cells. Biosci Rep 2: 15–30
Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, Tanzawa H
(2004) Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 down-
regulated in human oral squamous cell carcinoma. Int J Cancer 110:
225–231
Gazit G, Lu J, Lee AS (1999) De-regulation of GRP stress protein expression
in human breast cancer cell lines. Breast Cancer Res Treat 2: 135–146
Haeseleer F, Sokal I, Verlinde CLMJ, Erdjumnet-Bromage H, Tempst P,
Pronin AN (2000) Ca (2+)-binding proteins in the retina: structure,
function, and the etiology of human visual diseases. J Biol Chem 275:
1247–1260
Higo M, Uzawa K, Kawata T, Kato Y, Kouzu Y, Yamamoto N, Shibahara T,
Mizoe JE, Ito H, Tsujii H, Tanzawa H (2006) Enhancement of SPHK1 in
vitro by carbon ion irradiation in oral squamous cell carcinoma. Int J
Radiat Oncol Biol Phys 65: 867–875
Huang JK, Huang CJ, Chen WC, Liu SI, Hsu SS, Chang HT, Tseng LL, Chou
CT, Chang CH, Jan CR (2005) Independent [Ca
2+]i increases and cell
proliferation induced by the carcinogen safrole in human oral cancer
cells. Naunyn Schmiedebergs Arch Pharmacol 372: 88–94
Imazawa M, Hibi K, Fujitake S, Kodera Y, Ito K, Akiyama S, Nakao A (2005)
S100A2 overexpression is frequently observed in esophageal squamous
cell carcinoma. Anticancer Res 25: 1247–1250
Ishigami T, Uzawa K, Higo M, Nomura H, Saito K, Kato Y, Nakashima D,
Shiiba M, Bukawa H, Yokoe H, Kawata T, Ito H, Tanzawa H (2007) Genes
and molecular pathways related to radioresistance of oral squamous cell
carcinoma cells. Int J Cancer 120: 2262–2270
Ito T, Kawabe R, Kurasono Y, Hara M, Kitamura H, Fujita K, Kanisawa M
(1998) Expression of heat shock proteins in squamous cell carcinoma of
the tongue: an immunohistochemical study. J Oral Pathol Med 1: 18–22
Jones DT, Addison E, North JM, Lowdell MW, Hoffbrand AV, Mehta AB,
Ganeshaguru K, Folarin NI, Wickremasinghe RG (2004) Geldanamycin
and herbimycin A induce apoptotic killing of B chronic lymphocytic
leukemia cells and augment the cells’ sensitivity to cytotoxic drugs. Blood
5: 1855–1861
Kasamatsu A, Endo Y, Uzawa K, Nakashima D, Koike H, Hashitani S,
Numata T, Urade M, Tanzawa H (2005) Identification of candidate genes
associated with salivary adenoid cystic carcinomas using combined
comparative genomic hybridization and oligonucleotide microarray
analyses. Int J Biochem Cell Biol 37: 1869–1880
Kato H, Uzawa K, Onda T, Kato Y, Saito K, Nakashima D, Ogawara K,
Bukawa H, Yokoe H, Tanzawa H (2006) Down-regulation of 1D-myo-
inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral
squamous cell carcinoma. Int J Oncol 28: 873–881
Koch G, Smith M, Macer D, Webster P, Mortara R (1986) endoplasmic
reticulum contains a common, abundant calcium-binding glycoprotein,
endoplasmin. J Cell Sci 86: 217–232
Kubota H, Suzuki T, Lu J, Takahashi S, Sugita K, Sekiya S, Suzuki N (2005)
Increased expression of GRP94 protein is associated with decreased
sensitivity to X-rays in cervical cancer cell lines. Int J Radiat Biol 81:
701–709
Kunzelmann K (2005) Ion channels and cancer. J Membr Biol 205: 159–173
Lakshmikuttyamma A, Selvakumar P, Kanthan R, Kanthan SC, Sharma RK
(2004) Overexpression of m-calpain in human colorectal adenocarcino-
mas. Cancer Epidemiol Biomarkers Prev 13: 1604–1609
Lewis RS (2001) Calcium signaling mechanisms in T lymphocytes. Annu
Rev Immunol 19: 497–521
Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D (2000) Roles of PLC-2 and
-3 and the PI3K in chemoattractant-mediated signal transduction.
Science 287: 1046–1049
Lim SO, Park SG, Yoo JH, Park YM, Kim HJ, Jang KT, Cho JW, Yoo BC,
Jung GH, Park CK (2005) Expression of heat shock proteins (HSP27,
HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related
hepatocellular carcinomas and dysplastic nodules. 14: 2072–2079
Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS (1994) The glucose-
regulated proteins (GRP78 and GRP94): functions, gene regulation, and
applications. Crit Rev Eukaryot Gene Expr 4: 1–18
Moriyama-Kita M, Endo Y, Yonemura Y, Heizmann CW, Schafer BW,
Sasaki T, Yamamoto E (2004) Correlation of S100A4 expression with
invasion and metastasis in oral squamous cell carcinoma. Oral Oncol 40:
496–500
Nelson MR, Chazin WJ (1998) Calmodulin and Signal Transduction.
Academic Press: London
Pietas A, Schluns K, Marenholz I, Schafer BW, Heizmann CW, Petersen I
(2002) Molecular cloning and characterization of the human S100A14
gene encoding a novel member of the S100 family. Genomics 79: 513–522
Reddy RK, Lu J, Lee AS (1999) The endoplasmic reticulum chaperone
glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is
a novel proteolytic target of calpain during etoposide-induced apoptosis.
J Biol Chem 274: 28476–28483
Saito K, Uzawa K, Endo Y, Kato Y, Nakashima D, Ogawara K, Shiba M,
Bukawa H, Yokoe H, Tanzawa H (2006) Plasma membrane Ca2+ ATPase
isoform 1 down-regulated in human oral cancer. Oncol Rep 15: 49–55
Saito Y, Takazawa H, Uzawa K, Tanzawa H, Sato K (1998) Reduced
expression of E-cadherin in oral squamous cell carcinoma: relationship
with DNA methylation of 50 CpG island. Int J Oncol 12: 293–298
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki
N, Tanzawa H (2005) Aberrant expression of RAB1A in human tongue
cancer. Br J Cancer 92: 1915–1921
Sorger PK, Pelham HRB (1987) The glucose-regulated protein grp94 is
related to heat shock protein hsp90. J Mol Biol 2: 341–344
Soriano SF, Serrano A, Hernanz-Falcon P, Martin de Ana A, Monterrubio
M, Martinez C, Rodriguez-Frade JM, Mellado M (2003) Chemokines
integrate JAK/STAT and G-protein pathways during chemotaxis and
calcium flux responses. Eur J Immunol 33: 1328–1333
Takahashi K, Kanazawa H, Akiyama Y, Tazaki S, Takahara M, Muto T, Sato
K (1989) Establishment and characterization of a cell line (SAS) from
Ca
2þ-binding protein genes in OSCCs
H Nomura et al
800
British Journal of Cancer (2007) 97(6), 792–801 & 2007 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
spoorly differentiated human squamous-cell carcinoma of the tongue.
J Jpn Stomatol Soc 38: 20–28
Takenaga K, Nakamura Y, Sakiyama S (1997) Expression of antisense RNA
to S100A4 gene encoding an S100-related calcium-binding protein
suppresses metastatic potential of high-metastatic Lewis lung carcinoma
cells. Oncogene 14: 331–337
Thebault S, Flourakis M, Vanoverberghe K, Vandermoere F, Roudbaraki M,
Lehen’kyi V, Slomianny C, Beck B, Mariot P, Bonnal JL, Mauroy B, Shuba
Y, Capiod T, Skryma R, Prevarskaya N (2006) Differential role of
transient receptor potential channels in Ca2+ entry and proliferation of
prostate cancer epithelial cells. Cancer Res 66: 2038–2047
Thelen M (2001) Dancing to the tune of chemokines. Nat Immunol 12:
129–134
Tsai ST, Jin YT, Tsai WC, Wang ST, Lin YC, Chang MT, Wu LW (2005)
S100A2, a potential marker for early recurrence in early-stage oral
cancer. Oral Oncol 41: 349–357
Van Ginkel PR, Gee RL, Walker TM, Hu D-N, Heizmann CW, Polans AS
(1998) The identification and differential expression of calcium-binding
proteins associated with ocular melanoma. Biochim Biophys Acta 1448:
290–297
Van PN, Peter F, Soling HD (1989) Four intracisternal calcium-binding
glycoproteins from rat liver microsomes with high affinity for calcium.
No indication for calsequestrin-like proteins in inositol 1,4,5-trispho-
sphate-sensitive calcium sequestering rat liver vesicles. J Biol Chem 264:
17494–17501
Wang Q, He Z, Zhang J, Wang Y, Wang T, Tong S, Wang L, Wang S, Chen Y
(2005a) Overexpression of endoplasmic reticulum molecular chaperone
GRP94 and GRP78 in human lung cancer tissues and its significance.
Cancer Detect Prev 6: 544–551
Wang XP, Liu GZ, Song AL, Chen RF, Li HY, Liu Y (2005b) Expression and
significance of heat shock protein 70 and glucose-regulated protein 94 in
human esophageal carcinoma. World J Gastroenterol 11: 429–432
Wang XP, Qiu FR, Liu GZ, Chen RF (2005c) Correlation between
clinicopathology and expression of heat shock protein 70 and glucose-
regulated protein 94 in human colonic adenocarcinoma. World J
Gastroenterol 7: 1056–1059
Yin X, Zhang H, Burrows F, Zhang L, Shores CG (2005) Potent activity
of a novel dimeric heat shock protein 90 inhibitor against head and
neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 10:
3889–3896
Ca
2þ-binding protein genes in OSCCs
H Nomura et al
801
British Journal of Cancer (2007) 97(6), 792–801 & 2007 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
s